About: Vaccination of infants with a four-dose and a three-dose vaccination schedule

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Vaccination of infants with a four-dose and a three-dose vaccination schedule Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1999 (uk) article scientifique publié en 1999 (fr) im Dezember 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1999 (ast) scientific article published on 01 December 1999 (en) գիտական հոդված հրատարակված 1999 թվականի դեկտեմբերի 1-ին (hy)
publication date	wds:Q73224191-84DE54C9-BF41-451E-A97A-F68BDC818B0E
publication date	1999-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73224191-788C835F-4D6B-4106-804E-5442832E50FA
language of work or name	English
cites work	wds:Q73224191-01763E6F-621C-4B9A-91A8-7342D81BAE0C wds:Q73224191-228C8CBB-575B-4A8F-89EB-4BB0FE3673AE wds:Q73224191-2B4FA09D-1FD4-4DD0-913D-4C4B94773CC3 wds:Q73224191-31BECD7E-E840-4DCE-9854-DEB9CA339E6D wds:Q73224191-62897618-1E61-4095-BD62-0ADABAC4ED28 wds:Q73224191-68CC5AE2-5E25-42FB-92EC-7D9B23160467 wds:Q73224191-77DF63F2-CC98-4C07-B76B-730F41058664 wds:Q73224191-7DE4975B-7439-47E1-83CA-3583D4749931 wds:Q73224191-864821E9-CCF5-4CA9-942B-3FD83920EA94 wds:Q73224191-953174CE-15ED-4A5F-80F9-A643A4409816 wds:Q73224191-9A35BB65-4BB0-465C-8369-B6E1B7B418F8 wds:Q73224191-A1CC691D-19C2-41B1-90E5-DF1222C9FEDA wds:Q73224191-A791CE65-A39C-4667-9182-9EE469FFD48A wds:Q73224191-B346631E-093A-46AE-B2D4-0F0E38A3880D wds:Q73224191-C175640D-9743-4BDA-A77D-CEDDD42C02A2 wds:Q73224191-C390AB08-08EE-4694-ABE7-0246820B10EB wds:Q73224191-C9E1A128-393B-493F-ABAC-45D561988DA3 wds:Q73224191-D01E83AD-1CB4-4660-A8F0-CF37D9435C77 wds:Q73224191-E6E1A54C-38AC-4182-8E0B-5953AC45FDB6 wds:Q73224191-E9FE5227-F2FA-4694-96A3-5BDF2A72AC35 wds:Q73224191-F9DF4963-EE8B-4D25-9754-25AA5950018D
cites work	The impact of Haemophilus influenzae type b vaccination in Sweden. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b Specific immunoglobulin for treatment of whooping cough Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine A placebo-controlled trial of a pertussis-toxoid vaccine A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis A search for serologic correlates of immunity to Bordetella pertussis cough illnesses STUDIES ON ANTIBODY PRODUCTION. XI. VARIATION IN THE SECONDARY RESPONSE AS A FUNCTION OF THE LENGTH OF THE INTERVAL BETWEEN TWO ANTIGENIC STIMULI Induction of SerumHaemophilus influenzaeType B Capsular Antibodies in Adult Volunteers Fed Cross-ReactingEscherichia coli075:K100:H5 Diphtheria and tetanus toxoids Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts. Childhood immunisation in the European Union. Confederation of European Specialists in Paediatrics (CESP) Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. American Academy of Pediatrics Com
author name string	wds:Q73224191-0E260539-DEB8-4D40-820D-D997598CDC34 wds:Q73224191-63D2B5F9-D944-446F-A1D7-2435E236D616 wds:Q73224191-907FCAAF-A425-41DB-8882-C3647B564420 wds:Q73224191-9682EB5B-7B17-4C1E-B2DB-AFC40E57A855 wds:Q73224191-EC149911-2559-4E28-8B58-E9B644B6703D wds:Q73224191-F7C8C22C-4A7A-4D7D-A05B-44A8AE853026
author name string	E Ostergaard B Trollfors J Taranger T Lagergård V Sundh N Knutsson
rdfs:label	Vaccination of infants with a four-dose and a three-dose vaccination schedule (en) Vaccination of infants with a four-dose and a three-dose vaccination schedule (nl)
skos:prefLabel	Vaccination of infants with a four-dose and a three-dose vaccination schedule (en) Vaccination of infants with a four-dose and a three-dose vaccination schedule (nl)
name	Vaccination of infants with a four-dose and a three-dose vaccination schedule (en) Vaccination of infants with a four-dose and a three-dose vaccination schedule (nl)
title	wds:Q73224191-65F2086A-FCF5-40BB-9566-AA7BB7912254
title	Vaccination of infants with a four-dose and a three-dose vaccination schedule (en)
page(s)	wds:Q73224191-43B4124C-2763-41A4-853D-AE921FACE734
page(s)	884-891
instance of	wds:Q73224191-0602BD8E-5545-4E15-8984-123ADB869B49
instance of	scholarly article
PubMed ID	wds:Q73224191-EDF7FF95-A022-4035-A3C4-9990AA53EBBC
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10580202
PubMed ID	10580202
published in	wds:Q73224191-19B9CD74-1139-48E9-BA1C-2307E6CAA8D1
published in	Vaccine
issue	wds:Q73224191-6493CEE7-E030-402C-87D1-9EFBD3C47DAF
volume	wds:Q73224191-2E86BC00-7B14-4AFE-92E3-1CF8FECB7F03
issue	9-10
volume	18
DOI	wds:Q73224191-6ABBC5EC-F361-4362-8187-A19D7A091E97
DOI	http://dx.doi.org/10.1016/S0264-410X(99)00341-2
DOI	10.1016/S0264-410X(99)00341-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73224191
is cites work of	How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groups A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen The pertussis enigma: reconciling epidemiology, immunology and evolution Perplexities of pertussis: recent global epidemiological trends and their potential causes Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age. Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software